One Year of SARS-CoV-2: How Much Has the Virus Changed? DOI Creative Commons

Santiago Vilar,

Daniel G. Isom

Biology, Год журнала: 2021, Номер 10(2), С. 91 - 91

Опубликована: Янв. 26, 2021

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a worldwide crisis with profound effects on both public health and the economy. In order to combat COVID-19 pandemic, research groups have shared viral genome sequence data through Global Initiative Sharing All Influenza Data (GISAID). Over past year, ≈290,000 full SARS-CoV-2 proteome sequences been deposited in GISAID. Here, we used these assess rate of nonsynonymous mutants over entire proteome. Our analysis shows that proteins are mutating at substantially different rates, most exhibiting little mutational variability. As anticipated, our calculations capture previously reported mutations arose first months such as D614G (Spike), P323L (NSP12), R203K/G204R (Nucleocapsid), but they also identify more recent mutations, A222V L18F (Spike) A220V among others. comprehensive temporal geographical analyses show two distinct periods mutation rates: December 2019 July 2020 August 2020. Notably, some rates differ by geography, primarily during latter half Europe. Furthermore, structure-based molecular provides an exhaustive assessment context current set 3D structures available for proteins. This emerging sequence-to-structure insight is beginning illuminate site-specific (in)tolerance virus continues spread around globe.

Язык: Английский

SARS-CoV-2 (COVID-19) by the numbers DOI Creative Commons
Yinon M. Bar-On, Avi I. Flamholz, Rob Phillips

и другие.

eLife, Год журнала: 2020, Номер 9

Опубликована: Март 31, 2020

The COVID-19 pandemic is a harsh reminder of the fact that, whether in single human host or wave infection across continents, viral dynamics often story about numbers. In this article we provide one-stop, curated graphical source for key numbers (based mostly on peer-reviewed literature) SARS-CoV-2 virus that responsible pandemic. discussion framed around two broad themes: i) biology itself; ii) characteristics host.

Язык: Английский

Процитировано

1014

Genomic characterization of a novel SARS-CoV-2 DOI Open Access

Rozhgar A. Khailany,

Muhammad Safdar, Mehmet Özaslan

и другие.

Gene Reports, Год журнала: 2020, Номер 19, С. 100682 - 100682

Опубликована: Апрель 16, 2020

Язык: Английский

Процитировано

864

Variant analysis of SARS-CoV-2 genomes DOI Creative Commons
Takahiko Koyama, Daniel E. Platt, Laxmi Parida

и другие.

Bulletin of the World Health Organization, Год журнала: 2020, Номер 98(7), С. 495 - 504

Опубликована: Фев. 24, 2020

To analyse genome variants of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).

Язык: Английский

Процитировано

541

Higher infectivity of the SARS‐CoV‐2 new variants is associated with K417N/T, E484K, and N501Y mutants: An insight from structural data DOI Open Access
Abbas Khan, Tauqir Zia, Muhammad Suleman

и другие.

Journal of Cellular Physiology, Год журнала: 2021, Номер 236(10), С. 7045 - 7057

Опубликована: Март 23, 2021

Abstract The evolution of the SARS‐CoV‐2 new variants reported to be 70% more contagious than earlier one is now spreading fast worldwide. There an instant need discover how interact with host receptor (ACE2). Among mutations in Spike glycoprotein variants, three are specific receptor‐binding domain (RBD) and required insightful scrutiny for therapeutic options. These structural evolutions RBD may impart a critical role unique pathogenicity variants. Herein, using biophysical approaches, we explored that UK (N501Y), South African (K417N‐E484K‐N501Y), Brazilian (K417T‐E484K‐N501Y), hypothetical (N501Y‐E484K) alter binding affinity, create inter‐protein contacts changes internal dynamics thereby increases eventually infectivity. Our investigation highlighted (K417T‐E484K‐N501Y) lethal variant (N501Y). behavior wild type N501Y comparable. Free energy calculations further confirmed increased spike ACE2 mainly due electrostatic contribution. Further, find unusual virulence this virus potentially consequence Darwinian selection‐driven epistasis protein evolution. triple mutants (South Brazilian) pose serious threat efficacy already developed vaccine. analysis would help understand demand vitro vivo models design potential therapeutics against

Язык: Английский

Процитировано

346

D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization DOI Creative Commons
Drew Weissman, Mohamad‐Gabriel Alameh, Thushan I. de Silva

и другие.

Cell Host & Microbe, Год журнала: 2020, Номер 29(1), С. 23 - 31.e4

Опубликована: Дек. 1, 2020

Язык: Английский

Процитировано

341

Unbiased Screens Show CD8+ T Cells of COVID-19 Patients Recognize Shared Epitopes in SARS-CoV-2 that Largely Reside outside the Spike Protein DOI Creative Commons
Andrew Ferretti, Tomasz Kula, Yifan Wang

и другие.

Immunity, Год журнала: 2020, Номер 53(5), С. 1095 - 1107.e3

Опубликована: Окт. 20, 2020

Язык: Английский

Процитировано

336

The total number and mass of SARS-CoV-2 virions DOI Creative Commons
Ron Sender, Yinon M. Bar-On, Shmuel Gleizer

и другие.

Proceedings of the National Academy of Sciences, Год журнала: 2021, Номер 118(25)

Опубликована: Июнь 3, 2021

Quantitatively describing the time course of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection within an infected individual is important for understanding current global pandemic and possible ways to combat it. Here we integrate best knowledge about typical viral load SARS-CoV-2 in bodily fluids host tissues estimate total number mass virions person. We that each person carries 109 1011 during peak infection, with a range 1 μg 100 μg, which curiously implies all currently circulating human hosts have collective only 0.1 kg 10 kg. combine our estimates available literature on immune response mutation rates demonstrate how antibodies markedly outnumber spike proteins, genetic diversity covers single nucleotide substitutions.

Язык: Английский

Процитировано

244

SARS-COV-2 Variants: Differences and Potential of Immune Evasion DOI Creative Commons
Sandro Massao Hirabara, Tamires Duarte Afonso Serdan, Renata Gorjão

и другие.

Frontiers in Cellular and Infection Microbiology, Год журнала: 2022, Номер 11

Опубликована: Янв. 18, 2022

The structural spike (S) glycoprotein of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) plays an essential role in infection and is important target for neutralizing antibody recognition. Mutations the S gene can generate variants concern (VOCs), which improve "viral fitness" through selective or survival advantages, such as increased ACE-2 receptor affinity, infectivity, viral replication, higher transmissibility, resistance to antibodies immune escape, increasing disease severity reinfection risk. Five VOCs have been recognized include B.1.1.7 (U.K.), B.1.351 (South Africa), P.1 (Brazil), B.1.617.2 (India), B.1.1.529 (multiple countries). In this review, we addressed following critical points concerning VOCs: a) characteristics SARS-CoV-2 with mutations gene; b) possible evasion from generated vaccination, previous infection, therapies; c) potential risk new pandemic waves induced by worldwide; d) perspectives further studies actions aimed at preventing reducing impact during current COVID-19 pandemic.

Язык: Английский

Процитировано

208

Structural Characterization of SARS-CoV-2: Where We Are, and Where We Need to Be DOI Creative Commons
Giuseppina Mariano,

Rebecca J. Farthing,

Shamar L. M. Lale-Farjat

и другие.

Frontiers in Molecular Biosciences, Год журнала: 2020, Номер 7

Опубликована: Дек. 17, 2020

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has rapidly spread in humans almost every country, causing the disease COVID-19. Since start of COVID-19 pandemic, research efforts have been strongly directed towards obtaining a full understanding biology viral infection, order to develop vaccine and therapeutic approaches. In particular, structural studies allowed comprehend molecular basis underlying role many SARS-CoV-2 proteins, make rapid progress treatment preventive therapeutics. Despite great advances that provided by these studies, knowledge gaps on infection still remain. Filling will be key tackle this through development effective treatments specific vaccination strategies.

Язык: Английский

Процитировано

200

Definitions for coronavirus disease 2019 reinfection, relapse and PCR re-positivity DOI Creative Commons
Dafna Yahav, Dana Yelin, Isabella Eckerle

и другие.

Clinical Microbiology and Infection, Год журнала: 2020, Номер 27(3), С. 315 - 318

Опубликована: Дек. 5, 2020

Язык: Английский

Процитировано

198